4 completed, 3 unknown. 7 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 4, Unknown 3 |
Follow Ovarian Hyperstimulation Syndrome: new trials by email Literature Review of Ovarian Hyperstimulation Syndrome trials Research Report on Ovarian Hyperstimulation Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Letrozole Administration During Luteal Phase Letrozole, Polygeline, Sodium Chloride - Ovarian Hyperstimulation Syndrome | Phase 3 | Unknown | The Affiliated Hospital of Inner Mongolia Medical University | 50 | 2023-12-01 | 2023-07-20 |
| The Influence of Timing of Cabergoline Initiation on Prevention of OHSS Late Cabergoline 0.5mg, Early Cabergoline 0.5mg - Ovarian Hyperstimulation Syndrome | Phase 3 | Unknown | Mona M Shaban | 75 | 2017-12-20 | 2018-04-10 |
| Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET Triptorelin for Injection, Recombinant Human Choriogonadotropin alfa Solution for Injection, Progesterone Soft Capsules - Ovarian Hyperstimulation Syndrome | Phase 3 | Unknown | Changchun GeneScience Pharmaceutical Co., Ltd. | 252 | 2017-03-01 | 2017-03-06 |
| GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome GnRH antagonist (Cetrorelix), Placebo (saline solution) - Ovarian Hyperstimulation Syndrome, Effects of Gonadotropin | Phase 3 | Completed | Instituto Valenciano de Infertilidad, IVI VALENCIA | 100 | 2012-04-01 | 2013-09-19 |
| Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers Cabergoline, Placebo - Ovarian Hyperstimulation Syndrome | Phase 3 | Completed | KK Women's and Children's Hospital | 46 | 2012-04-01 | 2018-08-07 |
| Calcium for Prevention of Ovarian Hyperstimulation Syndrome calcium, 0.9 % saline - Ovarian Hyperstimulation Syndrome | Phase 3 | Completed | Cairo University | 200 | 2011-10-01 | 2014-07-09 |
| Cabergoline Reduces OHSS Cabergoline, MR, Ultrasound - Ovarian Hyperstimulation Syndrome | Phase 3 | Completed | Instituto Valenciano de Infertilidad, IVI VALENCIA | 60 | 2004-04-01 | 2007-02-27 |
Ascites (1)
Adnexal Diseases (7) · Endocrine System Diseases (7) · Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Genital Diseases (7) · Genital Diseases, Female (7) · Gonadal Disorders (7) · Ovarian Diseases (7) · Urogenital Diseases (7) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Cabergoline (3) · Sodium Chloride (2) · Calcium (1) · Dexamethasone (1) · Hematologic Tests (1) · High-Energy Shock Waves (1) · Injections (1) · Letrozole (1) · Polygeline (1) · Saline Solution (1) · Triptorelin Pamoate (1) · cetrorelix (1)
Instituto Valenciano de Infertilidad, IVI VALENCIA (2) · Cairo University (1) · Changchun GeneScience Pharmaceutical Co., Ltd. (1) · KK Women's and Children's Hospital (1) · Mona M Shaban (1) · The Affiliated Hospital of Inner Mongolia Medical University (1)
China (2) · Egypt (2) · Singapore (1) · Spain (1)
Antonio Pellicer, MD (1) · Juan Giles, MD (1) · Marianne Sybille Hendricks, MBBS, MRCOG (1) · Mona M Shaban, MD (1) · Rong Li, Doctor (1) · Waleed M El-Khayat, M.D. (1) · Xiujuan Chen, MD (1) · Yu Wang, PhD (1)